Search research articles
Contact Us
Filters
Showing results (121-130 of 534) with videos related to
Page
of 54
Sort By:
Clinical Pharmacology and Therapeutics
|
October 1, 1976
Amobarbital--a probe of hepatic drug oxidation in man
T Inaba, B K Tang, L Endrenyi, et al.
Molecular and Cellular Biology
|
March 1, 1997
Cell transformation mediated by homodimeric E2A-HLF transcription factors
T Inukai, T Inaba, T Yoshihara, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1977
A case of deficiency of N-hydroxylation of amobarbital
W Kalow, D Kadar, T Inaba, et al.
Biomedical Mass Spectrometry
|
October 1, 1982
Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometry
B K Tang, H Uchino, T Inaba, et al.
Molecular and Cellular Biology
|
September 19, 1998
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF
T Inukai, T Inaba, S Ikushima, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1982
Sparteine metabolism in Canadian Caucasians
A Vinks, T Inaba, S V Otton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase
T Inaba, M Jurima, W A Mahon, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1978
Distinctive patterns of amobarbital metabolites
W Kalow, B K Tang, D Kadar, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1978
Enzyme induction following a single dose of amobarbital in dogs
P A Reilly, T Inaba, D Kadar, et al.
Life Sciences
|
January 1, 1997
Evidence for the involvement of transforming growth factor-alpha in implantation in the rat
H Tamada, M Sakamoto, H Sakaguchi, et al.
Page
of 54
Search research articles
Search
Showing results (121-130 of 534) with videos related to
Sort By:
Page
of 54
Clinical Pharmacology and Therapeutics
|
October 1, 1976
Amobarbital--a probe of hepatic drug oxidation in man
T Inaba, B K Tang, L Endrenyi, et al.
Molecular and Cellular Biology
|
March 1, 1997
Cell transformation mediated by homodimeric E2A-HLF transcription factors
T Inukai, T Inaba, T Yoshihara, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1977
A case of deficiency of N-hydroxylation of amobarbital
W Kalow, D Kadar, T Inaba, et al.
Biomedical Mass Spectrometry
|
October 1, 1982
Simultaneous determination of antipyrine, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norantipyrine in urine by gas chromatography chemical ionization mass spectrometry
B K Tang, H Uchino, T Inaba, et al.
Molecular and Cellular Biology
|
September 19, 1998
The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF
T Inukai, T Inaba, S Ikushima, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1982
Sparteine metabolism in Canadian Caucasians
A Vinks, T Inaba, S V Otton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 1, 1985
In vitro inhibition studies of two isozymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase
T Inaba, M Jurima, W A Mahon, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1978
Distinctive patterns of amobarbital metabolites
W Kalow, B K Tang, D Kadar, et al.
Journal of Pharmacokinetics and Biopharmaceutics
|
August 1, 1978
Enzyme induction following a single dose of amobarbital in dogs
P A Reilly, T Inaba, D Kadar, et al.
Life Sciences
|
January 1, 1997
Evidence for the involvement of transforming growth factor-alpha in implantation in the rat
H Tamada, M Sakamoto, H Sakaguchi, et al.
Page
of 54